Your browser doesn't support javascript.
loading
Phase 2 study of all-oral ixazomib, cyclophosphamide and low-dose dexamethasone for relapsed/refractory multiple myeloma.
Kumar, Shaji K; Grzasko, Norbert; Delimpasi, Sosana; Jedrzejczak, Wieslaw W; Grosicki, Sebastian; Kyrtsonis, Marie-Christine; Spencer, Andrew; Gupta, Neeraj; Teng, Zhaoyang; Byrne, Catriona; Labotka, Richard; Dimopoulos, Meletios A.
Afiliación
  • Kumar SK; Division of Hematology, Mayo Clinic, Rochester, MN, USA.
  • Grzasko N; Department of Haematology, St. John's Cancer Centre, Lublin, Poland.
  • Delimpasi S; Department of Experimental Haemato-oncology, Medical University of Lublin, Lublin, Poland.
  • Jedrzejczak WW; Department of Haematology, Evangelismos Hospital, Athens, Greece.
  • Grosicki S; Department of Haematology and Oncology, Medical University of Warsaw, MTZ Clinical Research, Warsaw, Poland.
  • Kyrtsonis MC; Department of Cancer Prevention, Silesian Medical University, Katowice, Poland.
  • Spencer A; Haematology Section - 1st Department of Propaedeutic Internal Medicine, Laikon University Hospital, Athens, Greece.
  • Gupta N; Malignant Haematology and Stem Cell Transplantation Service, The Alfred Hospital/MONASH University/Australian Centre for Blood Diseases, Melbourne, Australia.
  • Teng Z; Millennium Pharmaceuticals, Inc., Cambridge, MA, USA.
  • Byrne C; Millennium Pharmaceuticals, Inc., Cambridge, MA, USA.
  • Labotka R; Millennium Pharmaceuticals, Inc., Cambridge, MA, USA.
  • Dimopoulos MA; Millennium Pharmaceuticals, Inc., Cambridge, MA, USA.
Br J Haematol ; 184(4): 536-546, 2019 02.
Article en En | MEDLINE | ID: mdl-30460684

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Mieloma Múltiple Tipo de estudio: Clinical_trials Idioma: En Revista: Br J Haematol Año: 2019 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Mieloma Múltiple Tipo de estudio: Clinical_trials Idioma: En Revista: Br J Haematol Año: 2019 Tipo del documento: Article